A securities class action has been filed in the USDC – N.D.IL. against Baxter International, Inc. (BAX) (“Baxter” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired Baxter common stock between February 23, 2022, and July 30, 2025, both dates inclusive (the “Class Period”). Baxter is a global, […]
A securities class action has been filed in the USDC – S.D.N.Y. against WPP Plc (WPP) (“WPP” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired WPP securities between February 27, 2025, and July 8, 2025, both dates inclusive (the “Class Period”). WPP is a global communications company […]
A securities class action has been filed in the USDC – S.D.N.Y. against MoonLake Immunotherapeutics (MLTX) (“MoonLake” or the “Company”), on behalf of all persons and entities that purchased or acquired MoonLake common stock between March 10, 2024, and September 29, 2025, both dates inclusive (the “Class Period”). MoonLake is a clinical-stage biotechnology company […]
recovered billions of dollars on behalf of investors. A securities class action has been filed in the USDC – S.D.CA. against aTyr Pharm, Inc. (ATYR) (“aTyr” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired aTyr common stock, purchased call options on aTyr common stock, and/or sold put options […]
A securities class action has been filed in the USDC – N.D.CA. against Cepton, Inc. (CPTN) (“Cepton” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired Cepton securities between July 29, 2024, and January 6, 2025, both dates inclusive (the “Class Period”). Prior to the Koito Acquisition, Cepton […]